The Department of Defense Breast Cancer Research Program offers the Impact Award, a grant designed to revolutionize breast cancer understanding, prevention, and treatment, aiming for major advances towards ending the disease. This grant encourages projects addressing critical, poorly understood issues like prevention, susceptibility, recurrence, or metastasis. The core focus is on research with the potential for an unprecedented, significant, and non-incremental impact on reducing incidence, recurrence, and mortality. Eligible projects span basic, translational, clinical, behavioral, and epidemiological research. Additionally, a Partnering PI Option facilitates meaningful collaborations between two investigators, allowing them to combine diverse expertise for enhanced research outcomes.
Opportunity ID: 146133
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-12-BCRP-IMPT |
| Funding Opportunity Title: | DOD Breast Cancer Impact Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 23, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 15, 2012 |
| Current Closing Date for Applications: | Aug 15, 2012 |
| Archive Date: | Sep 14, 2012 |
| Estimated Total Program Funding: | $15,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The BCRP Impact Award supports research projects (from small- to large-scale) that specifically focus on scientific and clinical breast cancer issues, which, if successfully addressed, will revolutionize the understanding, prevention, and/or treatment of breast cancer and make major advances toward the goal of ending the disease. The BCRP particularly encourages applications that focus on poorly understood issues that are of critical significance in breast cancer, such as those related to prevention, susceptibility, recurrence, or metastasis. The proposed work must be based on sound overall research and fully supported by preliminary data and/or published reports. Impact: The most important aspect of the Impact Award is the potential of the proposed research to have an unprecedented impact on reducing breast cancer incidence, recurrence, and/or mortality. The research project may be from any discipline or combination of disciplines, including basic, translational, clinical (clinical trials are allowed), behavioral, and/or epidemiological research. The potential impact may be near-term or long-term, but it must be significant and non-incremental. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate the potential impact on breast cancer and to convey its level of significance. Partnering PI Option: The Impact Award mechanism encourages applications that include meaningful and productive collaborations between investigators. The Partnering PI Option under the Impact Award mechanism is structured to accommodate two PIs, who will each receive a separate award. One partner is identified as the Initiating PI and the other partner is identified as the Partnering PI. The Initiating and Partnering PIs have different submission requirements; however, both PIs should contribute to the preparation of a single application. The collaborative partners may have expertise in similar or disparate scientific disciplines, but each partner is expected to bring different strengths to the application. New collaborations are encouraged, but not required. It is the responsibility of the collaborating investigators to describe how their combined expertise in the collaboration will better address the research question and explain why the work should be done together rather than through separate efforts. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk: 301-682-5507; help@cdmrp.org
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 146133 Full Announcement-1 -> fy12 bcrp impact pa_gg.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk: 301-682-5507; help@cdmrp.org Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00099431 | Feb 23, 2012 | Aug 15, 2012 | View |
Package 1
Mandatory forms
146133 RR_SF424_1_2-1.2.pdf
146133 PerformanceSite_1_4-1.4.pdf
146133 RR_Budget-1.1.pdf
Optional forms
146133 RR_SubawardBudget30-1.2.pdf
146133 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
